Should We Use Gene Editing to Create Super Babies?
By Katie Hasson,
The New York Times Upfront
| 02. 17. 2025
A young couple wants to have a baby, but they’re worried it’ll carry a disease that runs in the family. “There’s a solution,” the doctor says, “a technology that can alter the disease-causing gene in the egg, ensuring that the baby is born healthy.”
“How about giving our child blue eyes and musical talent?” the parents ask. “I think I can help you,” the doctor says.
Such a conversation once belonged only in the realm of science fiction. But with advances in gene-editing technologies such as CRISPR, fiction might become reality. In 2018, a doctor in China announced that he’d used CRISPR to edit twin girls’ DNA to protect them against the AIDS virus.
But not everyone thinks the world is ready for all the implications of tinkering with human genes. For instance, who’d get to decide which traits should be changed? And aren’t the traits we’re born with part of who we are? In a recent Pew Research Center study, about half of Americans agreed that it was “meddling with nature” and “a line we should...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...